FibroGen Inc (FGEN)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: FGEN Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-03-11 2024-03-07 B Purchase

Wettig Thane

CEO

Officer
50,000 +11.9%
1.91
95,470 USD 		50,000 +11.9% 1.91 95,470 USD
2023-09-06 2023-09-01 PS Planned sale

Henderson Jeffrey William

Non-Executive Director
2,000 -6.5%
1.03
2,060 USD 		2,000 -6.5% 1.03 2,060 USD
2023-08-08 2023-08-04 PS Planned sale

Henderson Jeffrey William

Non-Executive Director
2,000 -6.1%
1.91
3,820 USD 		2,000 -6.1% 1.91 3,820 USD
2023-07-13 2023-07-11 PS Planned sale

Henderson Jeffrey William

Non-Executive Director
2,000 -5.7%
2.69
5,380 USD 		2,000 -5.7% 2.69 5,380 USD
2023-07-10 2023-07-07 S Sale

Conterno Enrique A

Chief Executive Officer

Executive Director
1,880 -0.5%
2.80
5,264 USD 		1,880 -0.5% 2.80 5,264 USD
2023-06-26 2023-06-23 S Sale

Wettig Thane

Chief Commercial Officer

Officer
791 -0.7%
16.53
13,075 USD 		791 -0.7% 16.53 13,075 USD
2023-06-15 2023-06-14 PS Planned sale

Chung Christine

SVP, China Operations

Officer
1,000 -0.4%
17.46
17,460 USD 		1,000 -0.4% 17.46 17,460 USD
2023-06-15 2023-06-14 PS Planned sale

Chung Christine

SVP, China Operations

Officer
5,250 -2.2%
16.66
87,465 USD 		5,250 -2.2% 16.66 87,465 USD
2023-06-15 2023-06-13 PS Planned sale

Chung Christine

SVP, China Operations

Officer
6,250 -2.5%
17.60
110,000 USD 		6,250 -2.5% 17.60 110,000 USD
2023-06-09 2023-06-09 PS Planned sale

Brennan Aoife

Non-Executive Director
2,739 -8.9%
17.52
47,987 USD 		2,739 -8.9% 17.52 47,987 USD
2023-06-09 2023-06-09 PS Planned sale

Brennan Aoife

Non-Executive Director
1,994 -6.1%
16.74
33,380 USD 		1,994 -6.1% 16.74 33,380 USD
2023-06-09 2023-06-09 PS Planned sale

EDWARDS JEFFREY L

Non-Executive Director
4,624 -12.0%
17.51
80,966 USD 		4,624 -12.0% 17.51 80,966 USD
2023-06-09 2023-06-09 PS Planned sale

EDWARDS JEFFREY L

Non-Executive Director
3,265 -7.8%
16.74
54,656 USD 		3,265 -7.8% 16.74 54,656 USD
2023-06-09 2023-06-09 PS Planned sale

Blaug Suzanne

Non-Executive Director
5,169 -14.9%
17.51
90,509 USD 		5,169 -14.9% 17.51 90,509 USD
2023-06-09 2023-06-09 PS Planned sale

Blaug Suzanne

Non-Executive Director
3,351 -8.8%
16.73
56,062 USD 		3,351 -8.8% 16.73 56,062 USD
2023-06-09 2023-06-09 PS Planned sale

Cravatt Benjamin

Non-Executive Director
2,178 -7.0%
17.51
38,137 USD 		2,178 -7.0% 17.51 38,137 USD
2023-06-09 2023-06-09 PS Planned sale

Cravatt Benjamin

Non-Executive Director
1,766 -5.4%
16.75
29,581 USD 		1,766 -5.4% 16.75 29,581 USD
2023-06-09 2023-06-08 PS Planned sale

Henderson Jeffrey William

Non-Executive Director
4,994 -12.5%
17.69
88,344 USD 		4,994 -12.5% 17.69 88,344 USD
2023-06-09 2023-06-08 PS Planned sale

Henderson Jeffrey William

Non-Executive Director
2,006 -4.8%
16.87
33,841 USD 		2,006 -4.8% 16.87 33,841 USD
2023-06-09 2023-06-08 PS Planned sale

Ho Maykin

Non-Executive Director
6,225 -16.5%
17.68
110,058 USD 		6,225 -16.5% 17.68 110,058 USD
2023-06-09 2023-06-08 PS Planned sale

Ho Maykin

Non-Executive Director
2,295 -5.7%
16.79
38,533 USD 		2,295 -5.7% 16.79 38,533 USD
2023-06-09 2023-06-07 S Sale

Eisner Mark

EVP, Chief Medical Officer

Officer
2,042 -1.2%
17.04
34,792 USD 		2,042 -1.2% 17.04 34,792 USD
2023-06-09 2023-06-07 S Sale

Wettig Thane

Chief Commercial Officer

Officer
1,286 -1.1%
17.04
21,910 USD 		1,286 -1.1% 17.04 21,910 USD
2023-06-09 2023-06-07 PS Planned sale

Wettig Thane

Chief Commercial Officer

Officer
472 -0.4%
17.04
8,041 USD 		472 -0.4% 17.04 8,041 USD
2023-06-09 2023-06-07 S Sale

Conterno Enrique A

Chief Executive Officer

Executive Director
6,106 -1.6%
17.04
104,033 USD 		6,106 -1.6% 17.04 104,033 USD
2023-06-09 2023-06-07 PS Planned sale

Conterno Enrique A

Chief Executive Officer

Executive Director
2,791 -0.7%
17.04
47,550 USD 		2,791 -0.7% 17.04 47,550 USD
2023-06-09 2023-06-07 PS Planned sale

Schoeneck James A

Non-Executive Director
7,100 -8.8%
18.03
127,987 USD 		7,100 -8.8% 18.03 127,987 USD
2023-06-09 2023-06-07 S Sale

Graham Juan

Chief Financial Officer

Officer
735 -1.0%
17.04
12,523 USD 		735 -1.0% 17.04 12,523 USD
2023-06-09 2023-06-07 S Sale

Graham Juan

Chief Financial Officer

Officer
1,050 -1.4%
16.95
17,797 USD 		1,050 -1.4% 16.95 17,797 USD
2023-06-09 2023-06-07 S Sale

Chung Christine

SVP, China Operations

Officer
1,532 -0.6%
17.04
26,102 USD 		1,532 -0.6% 17.04 26,102 USD
2023-06-09 2023-06-07 S Sale

Chung Christine

SVP, China Operations

Officer
739 -0.3%
17.04
12,590 USD 		739 -0.3% 17.04 12,590 USD
2023-06-09 2023-06-07 S Sale

Chung Christine

SVP, China Operations

Officer
1,362 -0.5%
17.04
23,202 USD 		1,362 -0.5% 17.04 23,202 USD
2023-06-05 2023-06-02 S Sale

Eisner Mark

EVP, Chief Medical Officer

Officer
1,090 -0.7%
18.83
20,525 USD 		1,090 -0.7% 18.83 20,525 USD
2023-04-11 2023-04-10 S Sale

Conterno Enrique A

Chief Executive Officer

Executive Director
1,869 -0.5%
19.52
36,483 USD 		1,869 -0.5% 19.52 36,483 USD
2023-04-06 2023-04-04 S Sale

Eisner Mark

Chief Medical Officer

Officer
9,182 -5.2%
18.78
172,473 USD 		9,182 -5.2% 18.78 172,473 USD
2023-04-06 2023-04-04 S Sale

Chung Christine

SVP, China Operations

Officer
6,590 -2.5%
18.78
123,785 USD 		6,590 -2.5% 18.78 123,785 USD
2023-03-24 2023-03-23 S Sale

Wettig Thane

Chief Commercial Officer

Officer
905 -0.8%
18.71
16,933 USD 		905 -0.8% 18.71 16,933 USD
2023-03-10 2023-03-10 S Sale

Graham Juan

Chief Financial Officer

Officer
2,344 -3.1%
20.20
47,342 USD 		2,344 -3.1% 20.20 47,342 USD
2023-03-10 2023-03-10 S Sale

Graham Juan

Chief Financial Officer

Officer
1,456 -1.9%
20.20
29,407 USD 		1,456 -1.9% 20.20 29,407 USD
2023-03-10 2023-03-10 S Sale

Graham Juan

Chief Financial Officer

Officer
1,112 -1.4%
20.20
22,459 USD 		1,112 -1.4% 20.20 22,459 USD
2023-03-10 2023-03-10 S Sale

Conterno Enrique A

Chief Executive Officer

Executive Director
19,486 -4.8%
20.20
393,565 USD 		19,486 -4.8% 20.20 393,565 USD
2023-03-10 2023-03-10 S Sale

Conterno Enrique A

Chief Executive Officer

Executive Director
12,103 -2.9%
20.20
244,448 USD 		12,103 -2.9% 20.20 244,448 USD
2023-03-10 2023-03-10 S Sale

Eisner Mark

Chief Medical Officer

Officer
6,255 -3.4%
20.20
126,334 USD 		6,255 -3.4% 20.20 126,334 USD
2023-03-10 2023-03-10 S Sale

Eisner Mark

Chief Medical Officer

Officer
3,885 -2.1%
20.20
78,467 USD 		3,885 -2.1% 20.20 78,467 USD
2023-03-10 2023-03-10 S Sale

Wettig Thane

Chief Commercial Officer

Officer
4,731 -4.1%
20.20
95,553 USD 		4,731 -4.1% 20.20 95,553 USD
2023-03-10 2023-03-10 S Sale

Wettig Thane

Chief Commercial Officer

Officer
2,938 -2.5%
20.20
59,340 USD 		2,938 -2.5% 20.20 59,340 USD
2023-03-10 2023-03-10 S Sale

Chung Christine

SVP, China Operations

Officer
2,914 -1.1%
20.20
58,855 USD 		2,914 -1.1% 20.20 58,855 USD
2023-03-10 2023-03-10 S Sale

Chung Christine

SVP, China Operations

Officer
4,692 -1.8%
20.20
94,766 USD 		4,692 -1.8% 20.20 94,766 USD
2023-03-10 2023-03-08 S Sale

Graham Juan

Chief Financial Officer

Officer
2,749 -3.8%
21.16
58,158 USD 		2,749 -3.8% 21.16 58,158 USD
2023-03-10 2023-03-08 S Sale

Conterno Enrique A

Chief Executive Officer

Executive Director
24,672 -6.5%
21.16
521,958 USD 		24,672 -6.5% 21.16 521,958 USD
2023-03-10 2023-03-08 S Sale

Eisner Mark

Chief Medical Officer

Officer
7,363 -4.3%
21.16
155,771 USD 		7,363 -4.3% 21.16 155,771 USD
2023-03-10 2023-03-08 S Sale

Wettig Thane

Chief Commercial Officer

Officer
6,265 -5.7%
21.16
132,542 USD 		6,265 -5.7% 21.16 132,542 USD
2023-03-10 2023-03-08 S Sale

Chung Christine

SVP, China Operations

Officer
8,354 -3.2%
21.16
176,736 USD 		8,354 -3.2% 21.16 176,736 USD
2023-03-06 2023-03-02 S Sale

Eisner Mark

Chief Medical Officer

Officer
1,187 -0.7%
21.87
25,960 USD 		1,187 -0.7% 21.87 25,960 USD
2023-01-10 2023-01-06 PS Planned sale

Conterno Enrique A

Chief Executive Officer

Executive Director
1,538 -0.5%
19.95
30,683 USD 		1,538 -0.5% 19.95 30,683 USD
2022-12-28 2022-12-23 S Sale

Wettig Thane

Chief Commercial Officer

Officer
734 -0.8%
15.80
11,597 USD 		734 -0.8% 15.80 11,597 USD
2022-12-14 2022-12-12 PS Planned sale

Graham Juan

Chief Financial Officer

Officer
1,407 -2.6%
14.50
20,402 USD 		1,407 -2.6% 14.50 20,402 USD
2022-12-14 2022-12-09 S Sale

Graham Juan

Chief Financial Officer

Officer
781 -1.4%
14.90
11,637 USD 		781 -1.4% 14.90 11,637 USD
2022-12-15 2022-12-08 PS Planned sale

Graham Juan

Chief Financial Officer

Officer
478 -0.9%
15.47
7,395 USD 		478 -0.9% 15.47 7,395 USD
2022-12-15 2022-12-08 PS Planned sale

Graham Juan

Chief Financial Officer

Officer
5,263 -9.4%
14.84
78,103 USD 		5,263 -9.4% 14.84 78,103 USD
2022-12-09 2022-12-08 S Sale

Conterno Enrique A

Chief Executive Officer

Executive Director
2,543 -0.8%
15.79
40,154 USD 		2,543 -0.8% 15.79 40,154 USD
2022-12-09 2022-12-08 S Sale

Chung Christine

SVP, China Operations

Officer
1,096 -0.5%
15.79
17,306 USD 		1,096 -0.5% 15.79 17,306 USD
2022-12-09 2022-12-08 S Sale

Wettig Thane

Chief Commercial Officer

Officer
382 -0.4%
15.79
6,032 USD 		382 -0.4% 15.79 6,032 USD
2021-09-17 2021-09-15 S Sale

KEARNS THOMAS F JR

Non-Executive Director
13,100 -24.8%
11.58
151,707 USD 		13,100 -24.8% 11.58 151,707 USD
2021-03-15 2021-03-11 S Sale

KEARNS THOMAS F JR

Non-Executive Director
18,000 -10.8%
35.02
630,360 USD 		18,000 -10.8% 35.02 630,360 USD
2021-02-19 2021-02-17 PS Planned sale

Kurkijarvi Kalevi

Non-Executive Director
844 -2.5%
52.93
44,673 USD 		844 -2.5% 52.93 44,673 USD
2021-02-19 2021-02-17 PS Planned sale

Kurkijarvi Kalevi

Non-Executive Director
5,156 -13.2%
52.31
269,710 USD 		5,156 -13.2% 52.31 269,710 USD
2021-01-21 2021-01-19 PS Planned sale

Kurkijarvi Kalevi

Non-Executive Director
6,000 -15.3%
43.38
260,280 USD 		6,000 -15.3% 43.38 260,280 USD
2021-01-15 2021-01-14 PS Planned sale

Kurkijarvi Kalevi

Non-Executive Director
5,999 -15.3%
40.04
240,200 USD 		5,999 -15.3% 40.04 240,200 USD
2020-12-30 2020-12-28 PS Planned sale

Kurkijarvi Kalevi

Non-Executive Director
100 -0.3%
41.14
4,114 USD 		100 -0.3% 41.14 4,114 USD
2020-12-30 2020-12-28 PS Planned sale

Kurkijarvi Kalevi

Non-Executive Director
5,901 -15.1%
40.39
238,341 USD 		5,901 -15.1% 40.39 238,341 USD
2020-12-17 2020-12-16 PS Planned sale

Yu K Peony

Chief Medical Officer

Officer
3,350 -1.7%
41.61
139,394 USD 		3,350 -1.7% 41.61 139,394 USD
2020-12-17 2020-12-15 PS Planned sale

Cotroneo Pat

SVP, Finance and CFO

Officer
3,068 -1.1%
43.60
133,765 USD 		3,068 -1.1% 43.60 133,765 USD
2020-09-18 2020-09-16 PS Planned sale

Yu K Peony

Chief Medical Officer

Officer
3,351 -1.7%
44.01
147,478 USD 		3,351 -1.7% 44.01 147,478 USD
2020-09-17 2020-09-15 PS Planned sale

Cotroneo Pat

SVP, Finance and CFO

Officer
3,070 -1.1%
43.63
133,944 USD 		3,070 -1.1% 43.63 133,944 USD